Aurobindo Pharma Buys Parts Of Sandoz US From Novartis For $900 Million

Novartis AG said on Thursday it would sell the dermatology and generic US oral solids portfolios of Sandoz US to Aurobindo Pharma Ltd for $900 million, as the Swiss drug maker looks to focus on higher...

from NDTV News - Special https://ift.tt/2M2AW7m

Facebook Google Twitter More

• Pinterest
• Linkedin
• Tumblr

Posted by : Camera Guru 12:30 pm Tags : NDTV News - Special

Subscribe by Email

Follow Updates Articles from This Blog via Email